Vir Biotechnology Inc share price logo

Vir Biotechnology Inc Share Price

NASDAQ: VIR

Small Cap

$5.00

-0.23

(-4.30%)

as on

Vir Biotechnology Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $5.01
    $5.2
    downward going graph

    -0.20%

    Downside

    4.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.16
    $14.45
    downward going graph

    16.90%

    Downside

    189.00%

    Upside

    downward going graph

Vir Biotechnology Inc share price movements today

Previous Close
$5.23
Open
$5.20
Volume
894.6K
Day's Low - High
$5.01 - $5.2
52 Week Low - High
$4.16 - $14.45

Vir Biotechnology Inc Historical Returns

1 Month Return
+ 9.41 %
3 Month Return
-4.21 %
1 Year Return
-38.35 %
3 Year Return
-75.69 %
5 Year Return
-82.38 %

Vir Biotechnology Inc Stock Fundamentals & Key Indicators

Check Vir Biotechnology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$694.6M

EPS (TTM)

-3.2635

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.58%

PE Ratio (TTM)

-2.35

Industry PE ratio

-3.773885542168675

P/B Ratio

0

PEG Ratio

0

EBITDA

-554.7M

Revenue (TTM)

19.0M

Profit Margin

0.00%

Return On Equity TTM

240700.00%

Vir Biotechnology Inc Stock Valuation

Track how Vir Biotechnology Inc P/E has moved over time to understand its valuation trends.

Vir Biotechnology Inc in the last 5 years

  • Overview

  • Trends

Lowest (2.92x)

June 30, 2022

Industry (-3.77x)

September 13, 2025

Today (-2.35x)

September 13, 2025

Highest (10.10x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -2.35x

Vir Biotechnology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vir Biotechnology Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$694.6M-82.38%-2.350.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Vir Biotechnology Inc Stock including INR - Dollar returns

The Vir Biotechnology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vir Biotechnology Inc investment value today

Current value as on today

₹66,791

Returns

₹33,209

(-33.21%)

Returns from Vir Biotechnology Inc Stock

₹38,348 (-38.35%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Vir Biotechnology Inc Stock

Based on 13 analysts

BUY

69.23%

Buy

30.77%

Hold

0.00%

Sell

Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Vir Biotechnology Inc. Average target price of $17.22

Vir Biotechnology Inc Share Price Target

Get share price movements and forecasts by analysts on Vir Biotechnology Inc.

What analysts predicted

70.96%UPSIDE

Target Price

$17.22

Current Price

$5

Analyzed by

13 Analysts

Target

$17.22

Vir Biotechnology Inc target price $17.22, a slight upside of 70.96% compared to current price of $5. According to 13 analysts rating.

Vir Biotechnology Inc Stock's Interest Amongst Investors

Search interest for Vir Biotechnology Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Vir Biotechnology Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
46
-12
-4
16
56
3
2
11
1
1
Gross Profit
44
-12
-4
11
51
-1
2
10
1
1
Operating Income
-143
-215
-186
-117
-52
-129
-218
-117
-139
-118
EBITDA
-137
-205
-182
-134
-75
-128
-215
-114
-136
-118
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
5
4
4
4
4
4
2
2
2
2
Income Before Tax
-143
-197
-166
-120
-65
-139
-213
-104
-120
-110
Income Tax Expense
-2
-2
-3
-4
0
-1
0
0
0
0
Net Income
-140
-194
-163
-115
-65
-138
-213
-104
-120
-110
Net Profit Margin
-301.76%
1531.01%
3987.63%
-690.85%
-115.79%
-4500.10%
-8979.71%
-927.37%
-6742.75%
-9139.87%

Vir Biotechnology Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
76
1,087
1,580
86
74
Gross Profit
-62
-99
0
76
1,021
1,434
83
73
Operating Income
-81
-118
-177
-296
276
833
-684
-587
EBITDA
-81
-115
-173
514
420
833
-664
-537
Interest Expense
-
-
7
3
272
183
-
-
Depreciation
0
2
4
5
5
6
16
14
Income Before Tax
-80
-116
-174
-298
549
754
-628
-523
Income Tax Expense
-10
0
0
0
21
238
-13
-1
Net Income
-69
-115
-174
-298
528
515
-615
-521
Net Profit Margin
-46880.54%
-13350.69%
-24568.64%
-391.09%
48.62%
32.64%
-713.69%
-703.40%

Vir Biotechnology Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-194
-163
-115
-65
-138
-213
-104
-120
-110
Operating Cash Flow
-389
-155
-107
-109
-77
-171
-87
-78
-120
Investing Cash Flow
230
-58
-104
28
211
118
140
126
56
Financing Cash Flow
3
0
1
0
2
0
1
0
2
Change in Cash
-155
-214
-210
-80
136
-46
54
49
-61

Vir Biotechnology Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-115
-174
-298
528
515
-615
-521
Operating Cash Flow
-94
-129
-190
-47
1,663
-778
-446
Investing Cash Flow
-60
-256
-9
-140
-1,193
164
499
Financing Cash Flow
24
449
529
100
34
7
4
Change in Cash
-129
63
328
-88
504
-606
57

Global Institutional Holdings in Vir Biotechnology Inc

Funds
Holdings
SB INVESTMENT ADVISERS (UK) LTD
12.01%
BlackRock Inc
11.91%
Vanguard Group Inc
9.22%
State Street Corp
4.12%
Dimensional Fund Advisors, Inc.
1.93%

Insights on Vir Biotechnology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -120.96M → -110.95M (in $), with an average increase of 9.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 113.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 199.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 11.27M → 1.21M (in $), with an average decrease of 58.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VIR stock has moved down by -4.9%

About Vir Biotechnology Inc

vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
OrganisationVir Biotechnology Inc
Headquarters1800 Owens Street, San Francisco, CA, United States, 94158
IndustryCommercial Services
CEODr. Marianne De Backer M.B.A., M.Sc., Ph.D.
E-voting on sharesClick here to vote

Key Management of Vir Biotechnology Inc

Name

Title

Dr. Maninder Hora Ph.D.

Executive VP & Chief Technical Operations Officer

Dr. Jennifer Eileen Towne Ph.D.

Executive VP & Chief Scientific Officer

Mr. Toby Medaris

Senior Vice President of Human Resources

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

CEO & Director

Mr. Jason O'Byrne M.B.A.

Executive VP & CFO

Ms. Vanina de Verneuil J.D.

Executive VP, General Counsel & Corporate Secretary

Dr. Mark D. Eisner M.D., M.P.H.

Executive VP & Chief Medical Officer

Dr. Lawrence Corey M.D.

Co-Founder & Scientific Advisor

Dr. Louis J. Picker M.D.

Co-Founder & Scientific Advisor

Mr. Brent Sabatini

Senior VP, Principal Accounting Officer & Chief Accounting Officer

FAQs

What is Vir Biotechnology Inc share price today?

Vir Biotechnology Inc share price today is $5 as on at the close of the market. Vir Biotechnology Inc share today touched a day high of $5.2 and a low of $5.01.

What is the 52 week high and 52 week low for Vir Biotechnology Inc share?

Vir Biotechnology Inc share touched a 52 week high of $14.45 on and a 52 week low of $4.16 on . Vir Biotechnology Inc stock price today i.e. is closed at $5,which is 65.40% down from its 52 week high and 20.34% up from its 52 week low.

What is Vir Biotechnology Inc's market capitalisation today?

Vir Biotechnology Inc market capitalisation is $0.00T as on .

How to invest in Vir Biotechnology Inc Stock (VIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vir Biotechnology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vir Biotechnology Inc Shares that will get you 0.3000 shares as per Vir Biotechnology Inc share price of $5 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vir Biotechnology Inc Stock (VIR) from India?

Indian investors can start investing in Vir Biotechnology Inc (VIR) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Vir Biotechnology Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vir Biotechnology Inc share’s latest price of $5 as on September 13, 2025 at 1:29 am IST, you will get 2.0000 shares of Vir Biotechnology Inc. Learn more about fractional shares .

What are the returns that Vir Biotechnology Inc has given to Indian investors in the last 5 years?

Vir Biotechnology Inc stock has given -82.38% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?